28 results
424B5
BHVN
Biohaven Ltd.
19 Apr 24
Prospectus supplement for primary offering
6:02am
, we are currently in negotiations with a third party that may result in a near term commitment to issue $75 million of our common shares upon
424B5
BHVN
Biohaven Ltd.
17 Apr 24
Prospectus supplement for primary offering
4:01pm
with a third party that may result in a near term commitment to issue $75 million of our common shares upon execution of the amended agreement and another $75
8-K
EX-99.1
BHVN
Biohaven Ltd.
8 Jan 24
Regulation FD Disclosure
7:30am
| 42nd Annual J.P. Morgan Healthcare Conference55 Initiate Phase 1 Database Lock
Our Commitment: Building Value for Patients and Shareholders
8-K
EX-99.1
d1b8b
14 Nov 23
Biohaven Reports Third Quarter 2023 Financial Results and Recent Business Developments
4:26pm
8-K
EX-1.1
a1d4z4znae dkxeda3n
2 Oct 23
Other Events
9:41pm
8-K
EX-99.1
f4axyy6c
31 Jul 23
Biohaven Reports Second Quarter 2023 Financial Results and Recent Business Developments
4:29pm
8-K
EX-99.1
cb9c apgw
31 May 23
Biohaven Provides Overview of Clinical Progress, Regulatory Updates, and Pipeline Developments at R&D Day
7:03am
8-K
EX-99.1
6gzfsx
9 Nov 22
Biohaven LTD. Reports Third Quarter 2022 Financial Results and Reports Recent Business Developments
4:05pm
424B4
tbad0sm
24 Oct 22
Prospectus supplement with pricing info
9:38am
S-1/A
ghw599
20 Oct 22
IPO registration (amended)
10:00am
S-1
zoizord0vg0 d0k
18 Oct 22
IPO registration
4:03pm
S-8
EX-4.2
7hukynlc sgfj22fl6fm
11 Oct 22
Registration of securities for employees
4:31pm
DRS
5ccq3e5e4t xwh7
11 Oct 22
Draft registration statement
12:00am
10-12B/A
EX-99.1
ggnbo635gbxc ub
20 Sep 22
Registration of securities (amended)
6:30am
10-12B/A
EX-99.1
pz097cfwy
14 Sep 22
Registration of securities (amended)
5:25pm
10-12B/A
EX-99.1
3hfy92g0
7 Sep 22
Registration of securities (amended)
7:26am
10-12B/A
EX-10.11
uqr2au il7p05ox
7 Sep 22
Registration of securities (amended)
7:26am
10-12B/A
EX-10.12
wsakwnntdp1
7 Sep 22
Registration of securities (amended)
7:26am